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ABSTRACT
The eukaryotic polymerase processivity factor, PCNA,
interacts with cell cycle regulatory proteins such as
p21WAF1/Cip1 and Gadd45, as well as with proteins
involved in the mechanics of DNA repair and repli-
cation. A conserved PCNA-binding motif is found in a
subset of PCNA-interacting proteins, including p21,
suggesting that the regulation of these interactions is
important for the co-ordination of DNA replication and
repair. We have identified several classes of protein
which bind to Drosophila PCNA. Two of these proteins
contain the consensus PCNA-binding domain: one is
the Dacapo protein, a Drosophila homologue of
p21WAF1/Cip1, and the second is the transposase
encoded by the Pogo DNA transposon. A conserved
PCNA-binding domain is also present in a human
relative of Pogo, named Tigger, suggesting that this
domain has a functional role in this class of transpos-
able element. This raises interesting possibilities for a
novel method of transposition in which the transpo-
sase might be targeted to replicating DNA. Finally, we
have investigated the use of this conserved PCNA-
binding domain as a predictor of PCNA-binding
capacity.
INTRODUCTION
Proliferating cell nuclear antigen (PCNA) plays an essential role
in both the replication and repair of DNA. It forms a toroidal
shaped trimer which interacts non-specifically with DNA by
encircling it, forming a sliding clamp which tethers the polymer-
ase complex to the DNA duplex. PCNA is highly conserved and
has been identified in a very wide range of eukaryotes (1,2).
Genes showing sequence homology with PCNA have been
identified as far down the evolutionary ladder as the Archaea,
whose DNA replication and repair machinery appears to be more
typically eukaryotic then prokaryotic (3). The β subunit of
Escherichia coli polymerase III is a functional prokaryotic
homologue of PCNA and although this protein shows six-fold
symmetry like PCNA, it exists as a dimer rather than a trimer (4).
PCNA is an essential component of the DNA replication
machinery, acting as the processivity factor for polymerases δ and
ε (5,6). In addition to its role in replication, PCNA is also required
for nucleotide excision repair (7,8) and plays a role in one
pathway of base excision repair (9). Recent analysis of proteins
which interact with PCNA have shown that it interacts not only
with enzymes involved in the mechanics of DNA repair and
replication, but also binds to cell cycle regulatory proteins such
as p21 and Gadd45 (10–14). This suggests that the interaction of
PCNA with other proteins is a key regulatory target for the
co-ordination of DNA replication and repair.
PCNA in Drosophila is encoded by the mus209 gene:
mutations in mus209 result in lethality, although several mus209
mutants are temperature sensitive and provide unique tools to
analyse the functions of PCNA in a developing multicellular
organism (15). PCNA is required throughout development and
maternally encoded PCNA is essential for embryogenesis (15).
Analysis of the 5′-flanking region of mus209 indicates that its
transcription is regulated by homeodomain proteins, suggesting
that its expression is coordinated with cell proliferation and
differentiation (16). The mus209 mutants are highly sensitive to
a range of DNA damaging agents, supporting the role of PCNA in
DNA repair. The suppression of position effect variation seen in
these mutants points to a role for PCNA in chromatin assembly (15).
In a screen for proteins which interact with Drosophila PCNA,
we have identified several interacting proteins. Two of them,
which we describe here, have not previously been identified as
PCNA-binding proteins. One is the Dacapo protein, which is a
cyclin-dependent kinase inhibitor (17,18). The second is the
transposase encoded by the Pogo transposon, which belongs to
the TC1/Mariner superfamily of transposons (19). We find that
both proteins contain a consensus PCNA-binding domain shared
by other PCNA-binding proteins such as p21, Fen1, XPG and
MCMT (12,20–23). We find that a human relative of Pogo,
named Tigger, also potentially encodes a protein containing a
conserved PCNA-binding domain (24). This raises interesting
possibilities for a novel method of tranposition of such elements,
possibly by targeting the transposase to replicating DNA.
MATERIALS AND METHODS
Plasmid expression constructs and yeast two-hybrid methods
Manipulations of E.coli and DNA were by standard methods
(25). Double-stranded plasmid DNA was sequenced using the
Sequenase protocol (US Biochemical). The plasmids expressing
human, Drosophila and Schizosaccharomyces pombe PCNA
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have been described (12,14). Growth and maintenance of
Saccharomyces cerevisiae was according to standard methods
(26). Transformation was carried out by the method of Gietz et al.
(27). The S.cerevisiae strain Y190 (MATa leu2-3,112 ura3-52
trp1-901 his3-D200 ade2-101 gal4D gal80D cyhR
URA3::GAL1-lacZ LYS2::GAL1-HIS3) was used for all two-
hybrid analysis, which expresses the reporter genes lacZ (E.coli) and
HIS3 (S.cerevisiae) under the control of the GAL1 promoter. All
two-hybrid screening and analysis was carried out as previously
described (12,20). pACT plasmids identified in the two-hybrid
screening experiment were tested against pAS plasmids encoding
unrelated Gal4 fusion proteins to exclude false positive results: these
included pAS-Snf1, pAS-p53, pAS-Cdk2 and pAS-lamin (20).
Peptide analysis
The following 20 amino acid peptides were used (Chiron
Mimotopes, Australia). These peptides were linked via residues
SGSG at the N-terminus to biotin. p21, KRRQTSMTDFYHSK-
RRLIFS; p21-A, KRRATSMTDFYHSKRRLIFS; Dacapo,
RKRQPKITEFMKERKRLAQA; Dacapo-A, RKRAPKITEF-
MKERKRLAQA; Z50796, TKRQQKMTDFMAVSRKKNSL;
Z50796-A, TKRQQKMTDFMAVSRKKNSL; Pogo, KLFNL-
HINSAVLQKKITDYF; Pogo-A, KLFNLHINSAVLAKKIT-
DYF; Tigger, LMWQTSLLSYFKKLPQPPQP; Tigger-A,
LMWQTSLLSYFKKLPQPPQP; Consensus, KKRQKRLTDF-
FKRKRKLKEA; Consensus-A, KKRAKRLTDFFKRKRKLK-
EA; Unrelated, PESVELKWSEPNEEELIKFM.
ELISA analysis of PCNA binding to peptides
Plastic plates for enzyme-linked immunoabsorption assay
(ELISA) were coated with 100 µl 5 µg/ml streptavidin by drying
overnight at 37C. They were washed with phosphate-buffered
saline (PBS) containing 0.2% Tween 20 (PBST) and blocked with
5% non-fat milk powder in PBS for at least 2 h at room
temperature. Each well was incubated in turn with the following
reagents (the wells were extensively washed in PBST between
steps): (i) 0.5 µg peptide diluted in 100 µl 0.1% milk-PBS (2 h,
room temperature); (ii) up to 50 µg protein in 100 µl 0.1%
milk-PBS, either total cell lysates of E.coli BL21 expressing
human or S.pombe PCNA or purified human or S.pombe PCNA
(1 h, room temperature); (iii) primary anti-PCNA rabbit polyclo-
nal antiserum 3009 or PC10 monoclonal anti-PCNA antibody
diluted 1 in 2000 in 2% milk-PBS (1 h, room temperature);
(iv) secondary horseradish peroxidase (HRP)-conjugated anti-
rabbit or anti-mouse antibodies diluted 1 in 1000 in 2% milk-PBS
(1 h, room temperature); (v) 50 µl chromogenic substrate TMB
at 100 µg/ml in 0.1 M sodium acetate, pH 6.0, containing a 1 in
1000 diluted solution of H2O2 (30%). Once the colour reaction
had developed, the reaction was stopped by adding 50 µl 1 M
H2SO4 and the plate read using a Dynatech 5000 ELISA plate
reader at 450 nm.
Competition ELISA
Peptide ELISA experiments were carried out as described above,
with competing peptides added to the PCNA solution before
addition to the immobilized, biotinylated peptides. A p21-derived
peptide (KRRQTSMTDFYHSKRRLIFS) or an unrelated control
peptide (KPVRLPSIQAIPCAP) were dissolved in DMSO at
20 µg/mg and diluted in DMSO to various concentrations. The
DMSO-diluted peptides were then diluted 1 in 200 into a solution
of 0.1% milk-PBST containing purified human PCNA at 5 µg/ml,
immediately before adding to the peptide-coated wells.
Peptide pull-down experiments
An aliquot of 2.7 µg each peptide was incubated with 10 µl
streptavidin–agarose beads (Sigma) in PBS for 1 h at room
temperature, then the beads were washed extensively in PBS and
recovered each time by centrifugation. A sample of 20 µl
Drosophila embryonic extract was added to the washed beads at
a final concentration of 1 mg/ml and incubated with the beads on
ice for 1 h. The beads were extensively washed in PBS containing
0.05% Tween 20 and bound proteins removed by boiling in SDS
loading buffer. Proteins were separated by 15% SDS–PAGE then
electrophoretically transferred to PVDF membrane (Amersham).
The membranes were blocked in PBS containing 2% skimmed
milk for 30 min, then incubated for 1 h with a polyclonal rabbit
anti-Drosophila PCNA antibody diluted 1 in 1000 in 2%
skimmed milk-PBS. After washing, blots were incubated with
secondary HRP-conjugated swine anti-rabbit antibodies diluted
1 in 1000 in 2% skimmed milk-PBS for 30 min, followed by
washing in PBS containing 0.05% Tween 20. Bound antibody
was visualized using the ECL system according to the manufac-
turer’s instructions (Amersham).
Sequence analysis and profile searching
Sequence analysis was carried out using the UWGCG programs
at the Daresbury Seqnet facility and BLAST programs at the
NCBI web site (27,28). For profile searching, various combina-
tions of the amino acid sequences shown in Figure 7 were aligned
using the program PILEUP. These alignments were then used to
create a profile with PROFILEMAKE, with the default values of
GapWeight = 3.0 and GapLengthWeight = 0.1. The SWISSPROT
database Release 35 was searched using PROFILESEARCH
with the default values of GapWeight = 4.50 and GapLength-
Weight = 0.05; 59999 sequences were examined. Alignments
between the profile and the sequences thus found were created
with PROFILEGAPS. The various protein homologues shown in
Figure 7 were found with the database searching programs
BLASTP and FASTA. Protein sequence alignments were created
using a combination of PILEUP, LINEUP and BESTFIT and by
visual inspection.
RESULTS
Two-hybrid screening identifies PCNA-binding proteins
from Drosophila
In order to identify Drosophila proteins which interacted with
PCNA, we employed a yeast-based two-hybrid interaction
screening approach. Full-length Drosophila PCNA was ex-
pressed in yeast as a fusion protein with the DNA-binding domain
of S.cerevisiae Gal4 (12). This strain was then transformed with
a cDNA library in pACT derived from third instar larvae of
Drosophila melanogaster which expresses hybrid fusion con-
structs with the transcriptional activation domain of Gal4 (30).
Transformants where the two forms of hybrid protein interacted
were detected by their ability to form functionally active Gal4
complexes and thus activate Gal4-dependent reporter constructs.
Approximately 5 × 106 transformants were screened for their
ability to grow on medium containing 3-aminotriazole as a test for
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Figure 1. Schematic diagram of the protein sequences encoded by the Dacapo
clones identified in the two-hybrid screen against Drosophila PCNA. The red
box (residues 31–111) represents the consensus cyclin/CDK-binding domain.
The blue box indicates the position of the PCNA-binding consensus (residues
118–197) and these residues are shown beneath, along with the conserved
domain from C.elegans, mouse and human, where the blue boxes indicate
highly conserved residues within the domain.
expression of the reporter gene HIS3+. Of 55 His+ colonies, 20
also expressed detectable levels of β-galactosidase, indicating
that the other reporter gene, lacZ, was also expressed. The pACT
plasmids from these transformants were isolated and tested
against plasmids expressing various unrelated protein fusions to
test for specificity of interaction (Materials and Methods). From
sequence analysis, the clones fell into several classes, two of
which are described here.
Pogo and Dacapo proteins bind to the same region of PCNA
Three overlapping clones encoded the Dacapo protein, which has
been identified as encoding a cyclin-dependent kinase inhibitor
belonging to the p21/p27 class (17,18; Fig. 1). Although, like p27,
this protein has a predicted molecular weight of 27 kDa, this
identification of Dacapo as a PCNA-interacting protein indicates
that it belongs to the same functional family as the
p21WAF1/Cip1 subfamily (see Discussion). These three clones
contained 1.4, 1.0 and 0.9 kb cDNA inserts, which included
coding and 5′-untranslated regions. The smallest Dacapo clone
identified in this screen encoded the C-terminal 107 amino acids,
which does not include the predicted CDK/cyclin-binding
domains. Analysis of this sequence indicated that although the
overall homology between p21 family members and Dacapo is not
high, specific residues involved in PCNA binding are conserved
(Fig. 1; 12,31). Unlike human p21, Dacapo did not interact with
human Cdk2 in two-hybrid analysis (data not shown).
Three clones were identified in the two-hybrid screen which
contained sequences identical to the Pogo transposon (19; Fig. 2).
The largest clone starts upstream of the proposed start codon, but is
in-frame with the proposed open reading frame (ORF) of the Pogo
transposase and the second clone encodes amino acids 9–499. The
smallest Pogo clone encodes only the C-terminal 57 amino acids of
the Pogo transposase and defines the smallest region necessary for
PCNA interaction in this system. Examination of its predicted amino
acid sequence identified a region with homology to the consensus
PCNA-binding domains described above.
Since PCNA is a highly conserved eukaryotic protein, we used
the two-hybrid system to determine whether Dacapo and Pogo
could bind to PCNA from human and S.pombe. We found that in
both cases the interaction was evolutionarily conserved (data not
Figure 2. (Top) A schematic diagram of the Pogo transposon, showing TIRs
as black boxes and the two large ORFs which encode the Pogo transposase. The
regions corresponding to the inserts identified in the two-hybrid screen against
Drosophila PCNA are shown. The clones pDMpip11, pDMpip9 and
pDMpip12 contained cDNA inserts of ∼1.8, 1.6 and 0.3 kb, respectively.
(Bottom) An alignment between the C-terminal sequences of Pogo and the
second ORF of Tigger2. Identical residues are shown and + indicates a
conserved change.
shown). Since these proteins interact with human PCNA, it was
possible to test them using the yeast two-hybrid interaction assay
against a panel of human PCNA subclones designed for analysing
the domain specificity of human PCNA-binding proteins. The
results of these experiments show that Pogo and Dacapo bind to
the same region of PCNA as p21 and Fen1, which includes the
interdomain linker region (12,20; Fig. 3).
Pogo and Dacapo proteins contain conserved consensus
PCNA-binding domains
Examination of the smallest clones of Dacapo and Pogo identified
by two-hybrid screening (Figs 1 and 2) reveals that they contain
consensus PCNA-binding domains. This is consistent with the
observation that they bind to the same region of PCNA as the p21
and Fen1 proteins, which also contain this motif. In order to
determine whether these sequences do indeed represent PCNA-
binding domains, we obtained 20 amino acid synthetic peptides
corresponding to these regions which are linked to biotin through
a SGSG linker. The peptides tested represented PCNA-binding
domains from p21 homologues in human, Caenorhabditis
elegans and Drosophila (Dacapo) and from the transposases
encoded by Pogo and Tigger, a Pogo-related human transposon.
A peptide of a completely artificial sequence which represents a
consensus PCNA-binding sequence was also tested.
In order to ask whether these peptides were capable of binding
to Drosophila PCNA, they were conjugated to streptavidin–aga-
rose and incubated with the embryonic extracts. Following
extensive washing, bound proteins were analysed by immuno-
blotting using an anti-Drosophila PCNA polyclonal antibody.
The results in Figure 4 show that all the peptides examined bound
to Drosophila PCNA compared with an unrelated peptide, though
they showed varying affinities. The peptides derived from human
p21, Dacapo, the Tigger transposase and the artificially designed
consensus peptide all bound to PCNA to a similar degree. The
peptide derived from the predicted C.elegans p21 homologue
(Z50796) showed very poor binding to PCNA following the
washing stages, although it did significantly deplete the extract of
PCNA in the initial reaction. The Pogo-derived peptide, on the
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Figure 3. Two-hybrid domain analysis of PCNA binding to Dacapo and Pogo. The PCNA monomer showing the two structural domains is represented schematically.
A series of N- and C-terminal deletions of human PCNA (12) were expressed as fusions with the DNA-binding domains of Gal4. These were tested for their interactions
with the Dacapo- and Pogo-encoding two-hybrid isolates shown in Figures 1 and 2 as described in Material and Methods: each clone showed the same pattern of
interaction. These results were compared with those of previous experiments testing the pattern of interaction of Fen1, p21 and Gadd45 with these PCNA constructs
(12,14,20). These results suggest that p21, Fen1, Dacapo and Pogo interact with the same region of PCNA, while Gadd45 shows a different pattern of binding.
Figure 4. PCNA-binding domain peptides specifically interact with PCNA
from Drosophila embryonic extracts. Peptides conjugated to streptavidin–
agarose beads were incubated with Drosophila embryonic extracts and the
bound PCNA was analysed by SDS–PAGE followed by western blot analysis
with a polyclonal rabbit antibody to Drosophila PCNA. The peptides are
described in Materials and Methods and the numbered lanes show results as
follows; lane 1, p21; lane 2, Dacapo; lane 3, Z50796; lane 4, Pogo; lane 5,
Tigger; lane 6, Consensus; lane 7, Unrelated. (A) Western blot results of the
PCNA bound to the beads following washing in PBS containing 0.05% Tween
20 and (B) the PCNA remaining in the supernatant following depletion.
other hand, showed the highest affinity in this assay, almost
completely depleting the extract of PCNA.
In order to investigate the relative affinities of these peptides for
PCNA in an in vitro assay and to compare them with previously
identified PCNA-binding peptides, they were tested for interac-
tion with human PCNA in an ELISA-type assay. In these
experiments, peptides were also tested in which the conserved
glutamine (Q) was substituted by alanine (A). This residue is not
only highly conserved, but in the human p21-derived peptide this
mutation abrogates PCNA binding and the inhibition of DNA
replication (12). The results in Figure 5 show that each peptide
derived from the wild-type protein sequence was capable of
binding to human PCNA in this assay, with varying affinities. In
particular, the Pogo peptide showed a very high affinity in this
assay and the artificially designed peptide also binds strongly to
PCNA. These results are consistent with the results shown in
Figure 4 for binding to Drosophila PCNA. Mutation of the
conserved Q residue to A significantly reduced peptide affinity
for PCNA in each case, suggesting that this residue is specifically
required for the interaction.
In order to examine whether these peptides are binding to the
same region of PCNA as human p21, competition ELISA assays
were performed. In these experiments, the ability of each peptide
to bind to PCNA was tested in the presence of varying
Figure 5. ELISA analysis of peptide binding to PCNA. Biotinylated peptides
were immobilized on ELISA plates pre-coated with streptavidin and incubated
with purified human PCNA. Binding of PCNA to the immobilized peptides was
assessed using the anti-PCNA polyclonal rabbit antiserum 3009, followed by
HRP-conjugated anti-rabbit antibody and colorimetric detection at 450 nm.
Dark blue bars represent binding to peptides derived from the wild-type protein
sequence and light blue bars show results using the equivalent peptide with the
conserved Q residue substituted by A.
concentrations of the competing, non-biotinylated peptide
KRRQTSMTDFYHSKRRLIFS, which is derived from the
human p21 protein (Fig. 6). These results indicate that the p21
peptide was able to effectively compete for binding of PCNA to
the peptides tested, compared with a control peptide. This
strongly suggests that the peptides are binding to the same site
within PCNA as p21.
Use of the PCNA consensus as a tool for predicting
PCNA-binding proteins
Conserved protein motifs provide useful predictive tools for
examining the large numbers of sequences available in the public
domain databases. Proteins containing a consensus site can then
be tested biochemically for the predicted interaction. In the
PCNA-binding motif described here, only a subset of the residues
are highly conserved. The BLAST and FASTA algorithms, which
are commonly used for database searching, give an identical
weighting to each residue of the search sequence, so matched
sequences will not necessarily correspond to the consensus.
Therefore, to search for best matches to the overall PCNA-binding
consensus, we have used a profile search method, in which
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Figure 6. Competition ELISA analysis of peptide–PCNA interactions. Various
peptides (A, p21; B, Dacapo; C, Z50796; D, Consensus; E, Pogo; F, Tigger)
were immobilized in individual wells and their capacity to bind PCNA in the
presence of the non-biotinylated p21-derived peptide KRRQTSMTDFYHSK-
RRLIFS was tested by adding this peptide (closed squares) to the PCNA-
containing solution immediately before addition to the ELISA plate wells. An
unrelated peptide was used as a control for competition (open squares). The
OD450 (arbitrary units, x-axis), indicating the amount of PCNA bound, is
plotted against log10[competing peptide concentration in ng/ml] (y-axis). The
p21-derived peptide is able to compete effectively for PCNA binding in each
case, compared with the control peptide, strongly suggesting that the
p21-derived peptide is binding the same site on PCNA as the immobilized
peptide.
sequence alignments are used to construct an amino acid profile,
which is then used to search protein sequence databases.
The SWISSPROT database was searched using PROFILE-
SEARCH with profiles derived from various combinations of the
amino acid sequences shown in Figure 7 (Materials and Methods;
28). A selection of the highest scoring matches in eukaryotic
proteins, excluding input sequences, are shown in Figure 8.
Although these proteins contain a conserved PCNA-binding
domain, it is unlikely that there is a physiological interaction,
judging from their function and subcellular localization. We
conclude that the presence of a conserved PCNA-binding site
does not necessarily indicate a functional interaction.
One notable exception is the identification of a PCNA-binding
motif in the uracil-DNA glycosylase (UNG) protein of S.cerevi-
siae (ScUNG), which gave a very high score in several profile
searches. This protein functions in base excision repair (BER) to
remove mutagenic uracil residues resulting from the deamination
of cytosine in DNA (32). Recently, two forms of UNG protein
have been identified in human and mouse, which result from
alternative splicing events: Ung1 is targeted to mitochondria and
Ung2, in which the N-terminal 44 amino acids are encoded by a
previously unrecognized exon, is specifically targeted to the
nucleus (Fig. 9; 33). There is strong independent evidence that
this N-terminal region of Ung2, which contains a conserved
consensus PCNA-binding site, plays a role in nuclear targeting,
Figure 7. A conserved PCNA-binding motif. PCNA-binding domains are
shown in protein homologues of p21, Fen1, XPG, MCMT and Pogo
transposase. The accession number is indicated in the second column where
appropriate and the number in brackets in the third column indicates the
position of the first amino acid residue shown (where known). Identical residues
are highlighted in blue.
although any interaction with PCNA awaits biochemical analysis.
(33,34).
A number of the proteins described here are known by
immunofluorescence studies to be targeted (like PCNA itself) to
sites of DNA replication and/or repair (35–37; E.Warbrick,
P.Coates and P.A.Hall, unpublished observations). We therefore
searched for putative PCNA-binding domains in proteins known to
be targeted to replication foci. In this way, a consensus PCNA-bind-
ing motif was found at the N-terminus of DNA ligase I, which plays
an essential role in both DNA replication and nucleotide excision
repair and is known to be targeted to replication foci (39,40). The
predicted PCNA-binding motif is close to the N-terminus of the
protein and is conserved in a wide range of eukaryotes (Fig. 9).
Residues 2–115 of human DNA ligase I are essential for
replication foci localization and fine mapping has identified a
bipartite targeting sequence involving amino acids 1–28 and
111–179 (41,42). More recently, an interaction between the
N-terminal 118 amino acids of human DNA ligase I and PCNA
has been demonstrated, which can be disrupted by p21 (43). This
evidence provides strong support for our hypothesis that DNA
ligase I interacts with PCNA through the conserved motif shown
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Figure 8. Results of profile searching for PCNA-binding consensus motifs. Various combinations of the 20 amino acid sequences shown in Figure 7 were used to draw
up profiles and these were used to search the SWISSPROT database (Materials and Methods for details). A selection of the best eukaryotic protein matches, excluding
input sequences, are shown. All data shown here is described in the database entry for which the accession number is shown. Residues shown in blue are equivalent
to those which have direct PCNA interactions in the p21-derived PCNA-binding region and which are highly conserved between the sequences shown in Figure 7.
The function and subcellular localization of the majority of these proteins indicate that they are unlikely to interact with PCNA, with the notable exception of
S.cerevisiae ScUNG (see text for discussion).
Figure 9. Predicted PCNA binding motifs. (Top) Alignment of the N-terminal regions of uracil-DNA glycosylase (UNG) proteins from human, mouse and S.cerevisiae
(33,62), showing that a PCNA-binding motif is conserved in the specifically nuclear forms of UNG in mouse and human and in the yeast protein. Ung1 and Ung2
proteins are aligned up to the common splice site (#) and the S.cerevisiae sequence is aligned beneath. Identical residues are shown in colour and the stars indicate
the conserved residues of the predicted PCNA-binding motif. (Bottom) Alignment of the N-terminal regions of DNA ligase I homologues. The proteins shown are
(accession no. in brackets) from human (M36067), mouse (P37913), Xenopus (P51892), S.pombe (P12000) and S.cerevisiae (P04819). As above, identical residues
are shown in colour and the stars indicate the conserved residues of the predicted PCNA-binding motif.
in Figure 7. While this paper was in preparation, another group
also independently identified this motif and showed that the
activity of DNA ligase I can be inhibited by its interaction with
PCNA (44).
DISCUSSION
Dacapo is a member of the p21WAF1/Cip1 family of
CDK inhibitors
The p21/p27 family of CDK inhibitors are multifunctional
proteins which contain several functional domains. The N-ter-
minal region of these proteins contains domains that interact with
CDK/cyclin complexes, which are central to the regulation of the
cell cycle (45,46). Members of the p21 family are also capable of
binding to PCNA through a region in the C-terminus and this
domain is capable of inhibiting DNA replication in a PCNA-
dependent manner (12,47,48). Although identified as cyclin-
dependent kinase inhibitors, members of the p21/p27 family can
also promote the assembly of CDKs and cyclins and p21 (at low
molar ratios) can stimulate the kinase activity of these complexes
(49). Though p21, p27 and p57 are all capable of directing
accumulation of Cdk4 and cyclin D in the nucleus, p21 is
particularly efficient and the C-terminal region of the molecule is
required for this process. This region contains a bipartite nuclear
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localization signal which is coincident with the PCNA-binding
domain, suggesting that this region may be important somehow
for targeting p21 to specific sites within the nucleus. This issue is
complicated, however, by the existence of an adjacent, though
distinct, cyclin/CDK inhibitory domain in the C-terminus of p21
(50). An attractive model can be proposed in which, rather than
representing the sole point of contact with PCNA, the PCNA-
binding motif contained within p21, Fen1, XPG, MCMT, etc. is
involved primarily in targeting the proteins to the DNA repli-
cation machinery within the nucleus.
The Dacapo protein in D.melanogaster has been described as
belonging to the p21/p27 family of cyclin-dependent kinase
inhibitors (17,18). Here we describe identification of the protein
by its ability to bind to PCNA, which places it in the same
functional class as p21. Dacapo encodes an inhibitor of cyclin E/
Cdk2 and is required to regulate cell cycle arrest of epidermal
cells at the correct stage of embryogenesis. Unlike p21 in
mammalian systems, Dacapo is required for normal embryonic
development; loss of function mutants are lethal, with severe
developmental defects due to overproliferation (17,18,51).
Human p21 and Dacapo do not show a high overall homology
(25% identity), rather, the homology is restricted to the regions
required for CDK, cyclin and PCNA interactions. Within the
PCNA-binding motif, it is predominantly those residues required
for the interaction which are conserved (Fig. 1; 12,31).
The Pogo transposase interacts with PCNA
Pogo family transposons were first identified in Drosophila,
where they are no longer active (19). They are classified as DNA
or class II transposons which move by excision and re-integration
into the genome, without an RNA intermediate. Such elements
are flanked by terminal inverted repeats (TIRs) and encode a
transposase protein which binds specifically to the TIRs and
catalyses the cutting and pasting events which result in transposi-
tion. Mobility is dependent only upon the presence of the TIRs
and a catalytically active transposase protein, so non-autonomous
elements are as likely to be transposed as autonomous elements.
Recently, a study of the molecular archaeology of human
interspersed repeats with TIRs has revealed the presence of
several groups with the characteristics of type II DNA-mediated
transposons (24). These transposons are no longer mobile and
have been described as ‘molecular fossils’. The human TIR-
flanked repeats were analysed using consensus sequences from
multiple alignments and one group showed significant homology
to Pogo, both in the sequence of the TIRs and the coding sequence
(24). This group contained two classes of element: Tigger1, so
called as they represent a human Pogo (52), was primarily
represented by full-length elements, of which there are an
estimated 3000 copies in the human genome; Tigger2 is less well
characterized and its coding sequence cannot be unambiguously
defined, as it is less abundant and predominantly represented by
internal deletion products.
Here we describe the identification of a PCNA-binding motif
in the Pogo transposase and find that this motif is conserved in the
second ORF of the Tigger1 transposon. Equivalent domains from
both proteins are functional in binding to both Drosophila and
human PCNA. This evidence points to a specific function for the
domain, which raises many interesting issues concerning the role
of PCNA binding in transposase function. Since neither Tigger
nor Pogo transposons appear to be capable of transposition,
functional studies cannot be undertaken. However, it is tempting
to speculate that the transposase may utilize the relatively open
conformation of DNA around the replication fork to enhance
integration and/or excision. Type II DNA transposons move by a
cut-and-paste mechanism, so they do not proliferate unless
excision is followed by gap repair or the element moves from a
replicated to a still unreplicated part of the genome (53,54). This
raises the intriguing possibility that the interaction of the
Pogo/Tigger transposases with PCNA may be involved in
targeting integration to unreplicated portions of the genome.
Pogo contains two ORFs which are spliced to give a single ORF
encoding a predicted protein of 499 amino acids. The identifica-
tion of a functional PCNA-binding site in the second ORF of
Tigger1 suggests that, as is the case in Pogo, a single Tigger1
transcript was spliced to encode a single polypeptide.
Putative transposases in other organisms also show homology
to Pogo and Tigger. The most highly related are the Pot2 and Fot1
fungal transposases, which do not appear to contain a consensus
PCNA-binding domain, suggesting that an interaction with
PCNA is not a feature of all members of this family of transposons
(54,55). The Tigger and Pogo transposases also share homology
with cellular proteins, for example Pdc1 in S.cerevisiae and its
Kluyveromyces lactis homologue, Rag3, which are transcription
factors, and the murine proteins Jerky and CENP-B, which is a
eukaryotic centromere-associated protein (55–58). However, in
these cellular proteins, conserved residues known to be involved
in the transposase active site are mutated, suggesting that
transposase gene-encoded proteins have been adapted to a
cellular function. It is possible that the PCNA binding site in Pogo
and Tigger transposases was derived from a cellular PCNA-bind-
ing protein through an excision event.
Molecular analysis of the PCNA interaction
The PCNA-binding motifs shown in Figure 7 all share the
conserved residues QXX(h)XX(a)(a), where X is any amino acid,
(h) indicates residues with moderately hydrophobic side chains,
such as leucine, isoleucine or methionine, and (a) indicates
residues with highly hydrophobic aromatic side chains, e.g.
phenylalanine and tyrosine (60). p21 peptide–PCNA co-crystalli-
zation analysis shows that these conserved residues are involved
in direct interactions with the PCNA molecule: within the peptide
139GRKRRQTSMTDFYHSKRRLIFS160 the polar side chains
of Q144 and T145 form hydrogen bonds with the main chain
carbonyls of A252 and P253 in PCNA. The residues
146SMTDFY151 adopt a helical conformation, with M147, F150
and Y151 interacting with a hydrophobic cavity formed under the
connector loop of PCNA (31).
In the p21 peptide, the residues 139GRKRR143 are involved in
poorly ordered interactions with the acidic C-terminus of PCNA
(31). Human and mouse DNA ligase I homologues do not have
any amino acids N-terminal of the conserved Q, suggesting that
in these cases, there may not be an interaction with the C-terminus
of PCNA. The C-terminal amino acids of the p21 peptide
152HSKRRLIFS160 form an antiparallel β-sheet with the con-
nector loop and these amino acids have been shown to be
important in the inhibition of DNA replication by this peptide
(12,31). In the Pogo-derived peptide, which has a high affinity for
PCNA, these residues are absent. This indicates that the β-sheet
interaction with the interdomain linker region on PCNA is not
essential. However, this linker domain is also involved in forming
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/26/17/3925/1169934 by C
alifornia Institute of Technology user on 31 July 2020
 Nucleic Acids Research, 1998, Vol. 26, No. 173932
the hydrophobic pocket with which the X(h)XX(a)(a) motif
interacts, so is still essential for the interaction, as confirmed by
the results in Figure 3.
Summary
We present evidence that Dacapo and the transposase proteins
encoded by Pogo and Tigger bind to the same site on PCNA as
do p21 and Fen1, through a conserved QXX(h)XX(a)(a) motif.
Further, we show that an entirely synthetic peptide can be
designed based on consensus protein sequences which has a high
affinity of binding to PCNA. However, a close examination of the
PCNA-binding sequences suggests that the molecular interac-
tions of the proteins described here are varied outside the core
PCNA-binding domain. An analysis of the exact mechanisms of
how these proteins interact with PCNA and how the interactions
are coordinated and regulated will be important in understanding
the role PCNA plays as a target for cell cycle regulation.
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